Avalo Therapeutics, Inc. - COM NEW (AVTX)

Historical Portfolio Holders from Q4 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
6.66M
Holdings value Q3 2024
$63.2M
Value change Q3 2024
+$55.9M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
28
Number of buys Q3 2024
12
Number of sells Q3 2024
-3
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 6.66M $63.2M +$55.9M $9.50 28
2024 Q2 771K $9.62M +$8.43M $12.47 21
2024 Q1 87.5K $1.9M +$1.41M $21.75 18
2023 Q4 23K $209K +$209K $9.00 12